Evidence map›Paper›PMID 42355600›Full record

ArticleJournal of clinical medicine2026

Association of Pretreatment Serum Albumin and Systemic Inflammatory Markers with Pathologic Response to Neoadjuvant Chemotherapy in Breast Cancer.

Selçuk Cin, Merve Tokocin, Özgecan Gündoğar, Merve Cin, Ali Muhammedoğlu, Murat Yüce, Ahu Senem Demiröz

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Selçuk CinDepartment of Pathology, Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa, Istanbul 34098, Türkiye.ORCID 0000-0001-5097-0505
Merve TokocinDepartment of General Surgery, Bağcılar Training and Research Hospital, University of Health Sciences, Istanbul 34200, Türkiye.ORCID 0000-0001-8040-300X
Özgecan GündoğarDepartment of Pathology, Gaziosmanpaşa Training and Research Hospital, University of Health Sciences, Istanbul 34255, Türkiye.ORCID 0000-0003-3075-6063
Merve CinDepartment of Pathology, Istanbul Training and Research Hospital, University of Health Sciences, Istanbul 34080, Türkiye.ORCID 0000-0002-0656-497X
Ali MuhammedoğluDepartment of Pathology, Bağcılar Training and Research Hospital, University of Health Sciences, Istanbul 34200, Türkiye.
Murat YüceBiomedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.ORCID 0000-0003-0619-5868
Ahu Senem DemirözDepartment of Pathology, Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa, Istanbul 34098, Türkiye.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

breast cancerMiller–Payne gradingneoadjuvant chemotherapypathologic complete responseserum albumin

Identifiers

PMID42355600
PMCPMC13302650

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.